DSM N.V.
amsterdam : DSM

July 04, 2011 03:08 ET

DSM Completes Acquisition of Vitatene S.A.U.

HEERLEN, NETHERLANDS--(Marketwire - Jul 4, 2011) - Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has completed the acquisition of Vitatene S.A.U., based in León (Spain), a producer of natural carotenoids. The acquisition was announced on 10 May 2011. The acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow. Financial details of the acquisition will not be disclosed at this time.

Founded in 2004, Vitatene is a leader in the production and sale of a range of high-value natural carotenoid products derived from fermentation of the fungus Blakeslea trispora. The products are sold under the brandnames Betanat and Lyconat. The products are an addition to DSM's current portfolio of highly functional carotenoids, ranging from beta-carotene to lutein and zeaxanthin.

DSM - Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com

Press release-pdf: http://hugin.info/130663/R/1528031/463716.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1528031]

Contact Information

  • For more information:

    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact